Your browser doesn't support javascript.
loading
Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis.
Rosenbaum, Cara A; Özbek, Umut; Sanchez, Larysa; Lagdameo, Jonathan; Abrahams, Alex; Hassoun, Hani; Lahoud, Oscar; Niesvizky, Ruben; Landau, Heather J; Osman, Keren.
Afiliação
  • Rosenbaum CA; Weill Cornell Medicine, New York, NY.
  • Özbek U; Icahn School of Medicine at Mt. Sinai and the Mount Sinai Hospital, New York, NY; and.
  • Sanchez L; Icahn School of Medicine at Mt. Sinai and the Mount Sinai Hospital, New York, NY; and.
  • Lagdameo J; Icahn School of Medicine at Mt. Sinai and the Mount Sinai Hospital, New York, NY; and.
  • Abrahams A; Icahn School of Medicine at Mt. Sinai and the Mount Sinai Hospital, New York, NY; and.
  • Hassoun H; Weill Cornell Medicine, New York, NY.
  • Lahoud O; Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Niesvizky R; Weill Cornell Medicine, New York, NY.
  • Landau HJ; Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Osman K; Weill Cornell Medicine, New York, NY.
Blood Adv ; 6(18): 5436-5439, 2022 09 27.
Article em En | MEDLINE | ID: mdl-35858371

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article